Navigation Links
Researchers expand cyberspace to fight chronic condition in breast cancer survivors

COLUMBIA, Mo. Lymphedema is a chronic condition that causes swelling of the limbs and affects physical, mental and social health. It commonly occurs in breast cancer survivors and is the second-most dreaded effect of treatment, after cancer recurrence. Every day, researchers throughout the world learn more about the condition and how it can be treated. Now, University of Missouri researchers are developing a place in cyberspace where relevant and timely information can be easily stored, searched, and reviewed from anywhere with the goal of improving health care through the availability of up-to-date, evidence-based research.

"We want to bring researchers, medical professionals and care providers together to improve patients' health," said Chi-Ren Shyu, principal investigator for the project and director of the MU Informatics Institute. "Merging all of the data into one virtual space and discovering clinically significant knowledge from the haystacks of data will make cutting-edge research and treatments available to patients sooner."

Currently, people looking for information about lymphedema treatment have to visit dozens of medical websites or consult a best practices document, which has not been updated since 2006. The new system will enable immediate access to data, best practices, literature and research from around the world as it is posted online, all in a single, searchable online database.

"The cyber-infrastructure, once complete, can be applied to other diseases and chronic conditions, such as diabetes or cardiovascular disease," Shyu said. "Potential users include researchers, medical professionals, social workers, patients and their families."

Shyu and his informatics team from the College of Engineering are working with Jane Armer, professor in the MU Sinclair School of Nursing and director of the American Lymphedema Framework Project, housed at MU's Ellis Fischel Cancer Center. Their research is funded by a three-year grant awarded by the National Library of Medicine Applied Informatics Program.

In three years, Shyu and Armer plan to complete a system that automatically will pull research findings and new information from scientific journals and association websites through an automated data mining procedure. Shyu has an agreement with selected health care facilities from throughout the country to provide real-time, anonymous patient data so practitioners can understand how patients in different areas of the country are affected by lymphedema and its treatments.

"The development of an informatics depository for a data set holding key information for all patients with lymphedema of any cause offers enormous potential for answering research questions that are difficult to study with small data sets with varying criteria for lymphedema," said Armer. "This cyber-database will help us unlock the door to more immediate access to the latest information on evidence-based treatment and risk-reduction."


Contact: Emily Martin
University of Missouri-Columbia

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
Related Image:
Researchers expand cyberspace to fight chronic condition in breast cancer survivors
(Date:11/29/2015)... ... ... Key Housing, a top-rated corporate housing service for the San Jose and ... In showcasing this featured apartment community in San Jose, Key Housing is helping those ... find housing suitable to their needs by showcasing quality housing. , “San Jose many ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until ... most savings. , With possible savings of up to 20% off orders $80 or more ... of the website every few hours. , As a competitive e-commerce website for skin care ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... and the University of British Columbia suggested that laws requiring bicyclists to wear helmets ... that part of the reason for the controversial conclusion is that, while helmets have ...
(Date:11/27/2015)... PITTSBURGH, PA (PRWEB) , ... November 27, 2015 ... ... to be a safe and convenient way to dispense prescription medications at home, ... safe and effective way to monitor and dispense prescription medications. In doing so, ...
(Date:11/27/2015)... ... 27, 2015 , ... ProSidebar: Fashion is a set of 30 ... ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX production. ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease of ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
Breaking Medicine Technology: